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Abstract 45 
 46 
Introduction  Indoxyl sulfate (IS) and p cresyl sulfate (PCS) are protein bound 47 
toxins which accumulate with chronic kidney disease. Haemodiafiltration (HDF) 48 
increases middle molecule clearances and has been suggested to increase IS and 49 
PCS clearance. We therefore wished to establish whether higher convective 50 
clearances with HDF would reduce IS and PCS concentrations. 51 
Methods We measured total plasma IS and PCS in a cohort of 138 CKD5d 52 
patients treated by On-line HDF (Ol-HDF), by HPLC. 53 
Findings   Mean patient age was 64.6±16.5 years, 60.1% male, 57.3% 54 
diabetic, median dialysis vintage 25.9 months (12.4-62.0). The mean ICS 55 
concentration was 79.8±56.4 umol/l and PCS 140.3±101.8 umol/l.  On multivariate 56 
analysis, IS was associated with serum albumin (β 4.31,p<0.001), and negatively 57 
with residual renal function (β-4.1,p=0.02) and vegetarian diet(β -28.3,p=0.048) 58 
and PCS negatively with log CRP (β-75.8, p<0.001) and vegetarian diet (β -109, 59 
p=0.001). Vegetarian patients had lower IS and PCS levels (median 41.5 (24.2-60 
71.9) vs 78.1 (49.5-107.5) and PCS (41.6 (14.2-178.3) vs 127.3 (77.4-205.6) 61 
umol/l respectively, p<0.05. Vegetarian patients had lower preOl-HDF serum 62 
urea, and phosphate (13.8 ±3.8vs 18.4 ±5.2 mmol/l, and 1.33 ±0.21 vs1.58 ±0.45 63 
mmol/l), and estimated urea nitrogen intake (1.25±0.28 vs 1.62 ±0.5 g/kg/day ) 64 
respectively, all p<0.05 65 
Conclusions Plasma IS and PCS concentrations were not lower with Ol-HDF 66 
compared to previous studies in haemodialysis patients. However those eating a 67 
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vegetarian diet had reduced IS and PCS concentrations. Although this could be 68 
due to differences in dietary protein intake, a vegetarian diet may also 69 
potentially reduce IS and PCS production by the intestinal microbiome. 70 
  71 
 72 
Introduction 73 
Chronic kidney disease (CKD) leads to the accumulation of nitrogenous 74 
waste products of metabolism. The mortality of CKD patients treated by dialysis 75 
(CKD5d) remains high, and intuitively a greater amount of dialysis designed to 76 
remove these toxins would be expected to increase patient survival. The National 77 
Co-operative Dialysis Study (NCDS), demonstrated that short term patient 78 
outcomes were determined by the time averaged urea concentration. The results 79 
from the NCDS were used to define a critical threshold for haemodialysis urea 80 
clearance as a sessional Kt/Vurea [12]. However a subsequent randomised 81 
prospective haemodialysis study (HEMO study) [3], did not show that higher 82 
dialyzer urea clearances improved patient survival.  83 
Although urea accumulation can lead to carbamylation of haemoglobin and 84 
other proteins [4,5], urea is only one of a number of potential toxins that 85 
accumulate in CKD5d patients [6]. Serum beta 2 microglobulin, a middle sized 86 
azotaemic toxin, has been linked to an increased cardiovascular mortality and 87 
secondary analysis of the HEMO study also reported an association between 88 
increasing serum beta 2 microglobulin concentrations and mortality [7]. Although 89 
this effect of increasing  beta 2 microglobulin may be due to loss of residual renal 90 
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function, or inflammatory states, rather than  reduced dialyzer beta 2 91 
microglobulin clearance.   92 
As the prospective randomised Membrane Permeability Outcome (MPO) 93 
trial  was designed to compare high and low flux dialyzers did not observe any 94 
overall survival advantage with high flux dialyzers [8]. Although 95 
haemodiafiltration, which increases middle sized solute clearances [9], was 96 
described more than 50 years ago [10], it is only in recent times that 97 
haemodiafiltration has become an established treatment for many patients in 98 
Europe . Studies delivering the highest convective clearances reported a survival 99 
benefit for on-line haemodiafiltration (Ol-HDF) [11], whereas trials delivering 100 
lower convective doses did not [12]. Although these studies differed in patient 101 
characteristics including age, dialysis vintage and residual renal function ,there 102 
was a suggestion that Ol-HDF, by improving the spectrum of azotaemic toxin 103 
removal may increase dialysis patient survival [13]. There has been debate as to 104 
whether HDF increases clearance of indoxyl sulfate and p-cresyl sulfate, with 105 
some studies reporting increased clearance [14]. 106 
As such we wished to determine whether there was an effect of 107 
convection on the removal of these protein bound azotaemic toxins. 108 
 109 
Patients and methods 110 
We measured total plasma indoxyl sulfate and p-cresylsulfate in 138 111 
established chronic kidney dialysis patients attending for routine outpatient Ol-112 
HDF treatments under the care of the Royal Free Hospital, using Fresenius 113 
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4008H, 5008 (Fresenius AG, Bad Homburg, Germany) or BBraun Dialogue+ 114 
(BBraun, Melsungen, Germany) dialysis machines, with high flux polysulphone 115 
dialyzers (Nipro, Osaka, Japan) [15], and anticoagulated with tinzaparin (Leo 116 
Laboratories, Market Harborough, UK) [16]. Ultrapure quality water was used 117 
for all treatments. 118 
Serum biochemistry samples were analysed with a standard multi-channel 119 
biochemical analyzer (Roche Integra, Roche diagnostics, Lewes, UK), using the 120 
bromocresol green method for albumin determination, and the same assay for C 121 
reactive protein (CRP) as the UK National Amyloid Centre. Haemoglobin (Hb) was 122 
measured by the sodium lauryl sulphate-Hb method (XE-2100 Sysmex 123 
Corporation, Kobe, Japan) [17]. Serum beta-2-microglobulin was measured by 124 
rate nephelometry (www.Dako.com, Image 800 analyser, Beckman Coulter, High 125 
Wycombe, UK). Dialysate sodium delivery was checked by flame photometry and 126 
ion electrophoresis [18].  Patients were weighed pre and post haemodiafiltration 127 
using regularly calibrated scales and extracellular water to total body water 128 
measured with multifrequency bioelectrical impedance (Biospace 720, Biospace, 129 
Seoul, Korea) [19]. Protein nitrogen accumulation was estimated from pre and 130 
post dialysis urea concentrations and body water, and then normalised for body 131 
weight (nPNA) [20]. 132 
 Patients were reviewed by renally qualified dieticians, and dietary 133 
histories obtained by patient dietary recall. Residual renal function was 134 
measured from timed urine collections obtained between the 1st and 2nd  Ol-HDF 135 
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treatments of the week with corresponding blood tests, and expressed as the 136 
average of urea and creatinine clearance. 137 
 Indoxyl sulfate (IS) and p cresyl sulfate (p-CS) were measured by 138 
high pressure liquid chromatography (HPLC). In brief 200 ul plasma samples 139 
were incubated for 5 minutes at room temperature with 20uL of competitive 140 
inhibitor sodium caprylate (0.24 umol/l).  20uL of Internal standard naphthalene 141 
sulphonic acid (0.5 mmol/l) was added. Samples were deproteinated by addition 142 
of 2 ml ice cold acetone, centrifugation at 4000 rpm for 10 minutes followed by 143 
the addition of 2 ml ice cold dichloromethane to the resulting supernatant and 144 
further centrifugation at 4000 rpm for 10 minutes. The top aqueous phase was 145 
removed, stabilised with 20uL of 1M HCl and placed in a Waters 717 plus auto-146 
sampler (Waters Corporation, Milford, Massachusetts, USA) set at 15°C, 10 l 147 
sample injection, 20 minutes run time, 10 minutes delay. Samples were injected 148 
onto a Fortis C18 column (150 x 4.6 OD, 3 mM) (Fortis Technologies Ltd, Neston, 149 
Cheshire, UK) for peak separation using a Perkin Elmer Series 200 quaternary 150 
gradient pump (Perkin Elmer Life and Analytical Sciences, Shelton, Connecticut, 151 
USA) to control a mobile phase of A (0.2% trifluoroacetic acid in water) and 152 
B(0.2% trifluoroacetic acid in acetonitrile) with a gradient flow of %A/B 85/15 153 
for 5 minutes, 80/20 for 5 minutes, 0/100 for 2 minutes at 0.6 ml/minute flow 154 
rate, 0/100 for 3 minutes at 0.8 ml/min flow rate and 86/15 for 2 minutes at 1 155 
ml/minute flow rate. A Waters 2475 multi wavelength fluorescence detector 156 
was used to detect IS and internal standard at 280/360 nm and p-CS at 157 
260/296 nm excitation/emission wavelength. TotalChrom Navigator-900 158 
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software (Perkin Elmer Life and Analytical Sciences, Shelton, Connecticut, USA) 159 
was used to collate the peak data via a PE Nelson 900 Series interface [21]. 160 
 161 
Statistical analysis 162 
All categorical data were reported as number (percentage) and numeric 163 
data as mean ± standard deviation (SD). Comparison between two groups was 164 
performed with t test or Mann-Whitney U test for non-normally and non-165 
parametric distributed variables, or Chi square test with Yates’ correction. 166 
Nonparametric variables were log transformed for correlation analysis. Simple 167 
correlation was performed, and variables with p<0.1 were then included in a step 168 
backward multiple linear regression analysis to determine which variables were 169 
associated with indoxyl sulfate and p-cresyl sulfate concentrations. Variables 170 
which were not statistically significant were excluded from analysis unless they 171 
improved model fit. Data were analysis by SPSS statistic software (version 22, 172 
Chicago, USA). The level of significance was defined as a p value <0.05. 173 
Study approval was granted by the UK NHS national ethics committee 174 
IRAS project number 129559, and the study was undertaken in keeping the 175 
Helsinki accord with informed patient consent and trial registration 176 
ISRCTN70556765. 177 
 178 
Results 179 
Total plasma IS and P-CS concentrations were measured in 138 adult 180 
patients receiving Ol-HDF, mean age 64.6±16.5 years, 60.1% male, 57.3% 181 
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diabetic, median dialysis (Ol-HDF) vintage 25.9 months (12.4-62.0). Stoke-182 
Davies co-morbidity score 1.0 (1-1) and grade 1 (0-1) [22]. 51 patients were 183 
Caucasoid, 42 South Asian, 37 African-Afro-Caribbean with the remainder being 184 
Asian and one from North Africa. On dietary recall renally trained dieticians 185 
recorded that 16 patients were strict vegetarians and the remainder of the 186 
cohort were omnivores. 187 
Pretreatment haemoglobin was 110.1±17.4 g/l, serum albumin 39.3±4.2 g/l, 188 
urea 17.9±5.3 mmol/l, creatinine 677±254 umol/l, calcium 2.32± 0.13 mmol/l, 189 
phosphate 1.55±0.43mmol/l, glucose7.5±2.7 mmol/l , CRP 6mg/l (2.0-12.3 , β2 190 
microglobulin 28.9±10.6mg/l and median 24 hour urine volume 367ml (210-865). 191 
Median dialysis session time 3.75 hours (3.5-4.0), dialyzer surface area 2.1 m2 192 
(1.7-2.1), blood flow 300 ml/min (300-350), litres of convection 15.4 ±2.4 l, 193 
tinzaparin dose 2500 IU (1500-3500), dialysate sodium 136mmol/l (136-137). 194 
Sessional urea reduction ratio was 73.4±7.4%, and single pool Kt/Vurea 1.55±0.32, 195 
with a nPNA 1.58±0.48g/kg/day. Pre-dialysis weight 74.3± 17.3 kg, and 72.4±17.0 196 
kg post dialysis. Extracellular water/total body water ratio pre-dialysis was 197 
0.403±0.013 and post dialysis 0.395±0.021. 55 patients had some residual renal 198 
function, median creatinine clearance 0 (0-2.2) ml/min/1.73m2. 199 
54.4% of patients were prescribed antihypertensive medications, median 200 
number of classes of anti-hypertensive medications prescribed per patient 1 (0-201 
1). 43.9% were prescribed calcium containing phosphate binders, 25.2% 202 
sevelamer hydrochloride 25.2% and 4.3% lanthanum carbonate.  203 
9 
 
Simple univariate analysis was performed for both plasma IS and PCS 204 
(Table 1), and IS was most strongly associated with serum albumin and 205 
creatinine and negatively with residual renal function, whereas PCS the 206 
associations were weaker but positive for serum urea, and prescription of HMG 207 
CoA 3 reductase inhibitors (statins),and co-morbidity. There was no association 208 
with convection volumes delivered by Ol-HDF and PCS concentrations, and only a 209 
weak correlation between convection volume and IS (r2=0.04, p=0.049). However 210 
both IS and PCS were negatively associated with a vegetarian diet. We then 211 
performed a backward linear regression analysis (table 2), and IS was 212 
independently associated with serum albumin, and negatively with residual renal 213 
function and vegetarian diet. Whereas, PCS was associated with statin 214 
prescription and negatively with CRP and vegetarian diet. 215 
We then compared those eating a vegetarian diet to those consuming 216 
meat (table 3). Vegetarians had lower pre-dialysis serum urea and creatinine 217 
concentrations , and dietary nitrogen intake, but did not differ in residual renal 218 
function, or dialysis urea based clearances or convective volume exchange 219 
achieved. Both IS and PCS were lower in the vegetarian cohort (Figure 1). Serum 220 
phosphate was also lower (table3), despite more patients taking phosphate 221 
binders in the meat eaters (77.9% vs 43.8%, Chi square 8.97, p=0.03), with no 222 
difference in calcium containing phosphate binders prescribed compared to 223 
sevelamer or lanthanum (45.9 vs 31.3; 27.0 vs 12.5; and 4.9 vs 0%, respectively). 224 
Although there were no differences in sex, age or diabetes, more vegetarians 225 
were South Asians (meat eaters 40.9% Caucasoid, 21.3% South Asians and 226 
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30.3% African-Afro-Caribbeans, and vegetarians 6.3% Caucasoids; 93.7% South 227 
Asians, and 0% African-Afro-Caribbeans respectively, Chi square 35.6,p<0.001). 228 
Correcting muscle mass and body fat for height, to derive muscle and fat 229 
indices, then the vegetarian cohort had lower muscle mass, but fat mass was 230 
similar (p=0.052) (Figure 2). 231 
 232 
Discussion 233 
  Indoxyl sulfate and P cresyl sulfate are protein bound toxins which 234 
accumulate in patients with chronic kidney disease treated by dialysis. Plasma 235 
total concentrations in our cohort are similar to those reported from previous 236 
studies in dialysis patients [23]. Although earlier reports suggested that 237 
convective dialysis therapies could lead to a reduction in IS and PCS [24], we 238 
only observed a weak association between the Ol-HDF convective dose and IS 239 
concentrations, and other reports showed no difference in IS or PCS 240 
concentrations and different convective therapies [25]. Comparing our cross 241 
sectional cohort data with previous studies, then treatment with Ol-HDF does 242 
not appear to lead to a substantial reduction in protein bound solutes. We only 243 
found a modest association and dialysis session duration, in keeping with previous 244 
reports of marginal differences in IS and PCS plasma concentrations and 245 
dialysis session time. Increasing dialyzer surface area has previously been 246 
suggested to increase clearance [26], we only found a weak univariate 247 
association between plasma IS and PCS and dialyzer surface area, that was lost 248 
on multiple linear regression. As we had standardised dialysate flow rates we did 249 
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not examine the effect of different dialysate flow rates [26], but there was no 250 
effect of convection volume and PCS concentrations and only a very modest 251 
univariate association with IS concentrations. 252 
There was no association between dialytic urea clearance or convective volume 253 
exchange and PCS concentrations, but there were weak univariate associations 254 
for IS, which were lost on multivariate analysis. In keeping with previous 255 
observations IS concentrations were lower in those dialysis patients who had 256 
retained residual renal function [27].  257 
 IS and indoxyl glucuronide are produced from tryptophan derived indoles 258 
following intestinal bacterial metabolism, whereas p-cresyl sulfate and p-cresyl 259 
glucuronide are derived from p-cresol following bacterial metabolism of 260 
tyrosine. Both are then predominantly bound by albumin. Generally on univariate 261 
analysis we found an association between those variables associated with 262 
increased protein intake, protein turnover, whereas there was a negative 263 
association with residual renal function and those variables associated with 264 
reduced dietary intake. On multivariate analysis, IS was associated with albumin, 265 
which is generally a marker of health and nutritional status, and negatively with 266 
residual renal function and vegetarian diet. Similarly PCS was associated with 267 
statin prescription, a potential surrogate for cardiovascular disease, and also 268 
dietary intake, and these protein bound toxins have been linked to increased 269 
cardiovascular risk for dialysis patients [28]. We suspect that the negative 270 
association with CRP could be secondary to the negative effects of low grade 271 
inflammation on dietary intake. Although it is recognised that acute illnesses can 272 
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affect the gastrointestinal biome, and so by altering bacterial numbers and 273 
populations could also have an effect in reducing production of these gut derived 274 
uraemic toxins [29]. 275 
In our dialysis cohort we had a group of predominantly South Asian 276 
vegetarians, who had lower plasma IS and PCS levels than their meat eating 277 
counterparts. Residual renal function and dialysis treatments were not 278 
different. However these vegetarian patients did have a lower estimated 279 
dietary protein intake, and lower predialysis serum urea and creatinine 280 
concentrations, and lower muscle mass, but similar fat mass. Our study is the 281 
first to report that a vegetarian diet leads to lower IS and PCS levels in kidney 282 
dialysis patients. Our results are supported by previous studies which have 283 
reported that low protein diets reduce serum concentrations of protein bound 284 
azotaemic toxins [30], and a small study which reported that the production 285 
rate of IS and PCS were lower in healthy vegetarians compared to healthy 286 
omnivores [31]. In addition, serum phosphate concentrations were also lower, 287 
despite fewer patients prescribed phosphate binders, and studies in vegetarian 288 
chronic kidney disease patients have also reported lower phosphate levels 289 
thought to be due to differences in plant phytate intake [32].  290 
The bacterial population in the colon changes in patients with chronic 291 
kidney failure [29], with a switch to more bacteria capable of producing IS and 292 
PCS. It is equally recognised that not only sudden changes in health, but abrupt 293 
changes in dietary intake can also lead to changes in the gastrointestinal 294 
microbiome [29]. There are differences between animal and vegetable proteins, 295 
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and as such, the lower IS and PCS concentrations we report in our vegetarian 296 
patients could potentially lead to differences in gut bacterial populations and 297 
reduced IS and PCS production.  Other studies have shown that a deliberate 298 
intervention to  increase in dietary fibre for 6 weeks can also reduce IS and 299 
PCS concentrations [33] We do not think that this would have a major effect in 300 
our dialysis population due to the dietary advice given to restrict higher 301 
phosphate containing foodstuffs, such as bran and other high fibre foodstuffs. 302 
The majority of our vegetarian patients came for the South Asian community, 303 
and this group of patients have better 5 year survival on dialysis than Northern 304 
Europeans.  Although our study is cross sectional, we report for the first time 305 
that vegetarian dialysis patients have lower IS and PCS levels , and as such 306 
further prospective interventional studies are required to investigate whether 307 
changes in diet can reduce protein bound and other uraemic toxins [34].  308 
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Figure 1. Plasma concentrations of indoxyl sulfate and p cresyl sulfate in non-485 
vegetarian and vegetarian patients. Results expressed as median (interquartile 486 
range).* p<0.05  vs non-vegetarian 487 
 488 
 489 
Figure 2. Muscle and Fat mass measured post haemodiafiltration by 490 
multifrequency bioimpedance indexed to height. Results expressed as median 491 
(interquartile range) * p<0.05 vs non-vegetarian. 492 
 493 
 494 
 495 
 496 
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 498 
 499 
 500 
Table1. Pearson correlation analysis for indoxylsulfate (IS) and p-cresyl sulfate 501 
(PCS).Nonparametric data were transformed prior to analysis. Serum variables  502 
pre midweek dialysis session. Residual renal function (RRF -combined 24 hour 503 
urinary urea and creatinine clearance),dialyzer surface area (dialyzer) Number 504 
of classes of antihypertensive medications (No BPmeds), sessional Kt/V 505 
(Kt/V),dialysate potassium (Potassium D, sodium (Dialysate Na),β2 microglobulin 506 
(β2M), phosphate binders (binders), total body water(TBW), litres ofconvective 507 
clearance (litres), prescription HMG CoA 3 reductase inhibitor (statin),Stoke-508 
Davies Co-morbidity grade (comorbidity),dialysis session time (time), C reactive 509 
protein (CRP),g urea nitrogen/kg/day .G N/day/kg 510 
 511 
IS r p PCS r p 
PCS 0.362 <0.001 IS 0.362 <0.001 
albumin 0.328 <0.001 statin 0.267 0.002 
creatinine 0.324 <0.001 urea 0.206 0.015 
RRF -0.266 0.002 comorbidity 0.209 0.016 
dialyzer 0.233 0.006 vegetarian -0.197 0.020 
No BP meds 0.225 0.008 CRP -0.18 0.035 
Kt/V -0.204 0.014 G N/day/kg 0.172 0.044 
Potassium D -0.192 0.024 time 0.170 0.046 
vegetarian -0.192 0.024    
Sodium D -0.182 0.033    
β2 M 0.184 0.031    
binders 0.174 0.041    
TBW -0.182 0.045    
litres 0.199 0.049    
 512 
 513 
 514 
 515 
Table2;multiple linear regression analysis for indoxylsulfate (IS) and p-cresyl 516 
sulfate (PCS). Residual renal function (RRF -combined 24 hour urinary urea and 517 
creatinine clearance). C reactive protein (CRP), prescription HMG CoA 3 518 
reductase inhibitor (statin). Standard error of β (SE),confidence limits (CL).ICS 519 
model corrected r2= 0.179,and PCS,r2=0.235 520 
 521 
ICS β SE t 95% CL F p 
albumin 4.31 1.1 4.02 2.2 to6.4 16.1 <0.001 
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RRF -4.1 1.3 -3.1 -6.7 to-1.5 0.87 0.02 
vegetarian -28.3 14.2 -1.99 -56.4to-0.24 0.98 0.048 
PCS       
CRP -75.8 19.4 -3.9 -114 to -37 15.4 <0.001 
vegetarian -109 31.8 -3.4 -172to -46 11.8 0.001 
statin 49.1 19.1 2.4 11.1to 87.0 6.6 0.012 
 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
Table3: Patient demographics of those who were vegetarian and those who were 532 
non-vegetarian. Serum values pre mid- week dialysis session, and body 533 
composition postdialysis. Extra cellularwater (ECW) total body water (TBW), 534 
Residual renal function (RRF -combined 24 hour urinary urea and creatinine 535 
clearance), C reactive protein (CRP). Chi square (X2) 536 
 537 
 538 
variable Non vegetarian vegetarian P value 
Age yr 63.7 ±16.9 71.7 ±11.6 0.07 
Male % 59.0 68.8 X2=0.5,p>0.5 
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Diabetic % 55.7 68.9 X2=0.27,p>0.5 
Vintage months 25.7 (13.5-62) 29.8 (10.9-69.2) 0.97 
RRF ml/min1.73m2 0 (0-2.2) 0 (0-1.2) 0.23 
Weight kg 71.7 ±18.1 65.6 ±12.1 0.20 
BMI kg/m2 26.5 ± 6.0 25.4 ± 5.2 0.50 
ECW/TBW 0.394 ±0.022 0.399 ±0.016 0.39 
Haemoglobin g/l 109.3 ±17.8 116.1 ±12.9 0.15 
Albumin g/l 39.4 ±4.3 38.7 ±3.5 0.53 
Urea mmol/l 18.4 ±5.2 13.8 ±3.8 <0.01 
Creatinine umol/l 699 ±258 503 ±115 <0.01 
Phosphate mmol/l 1.58 ±0.45 1.33 ±0.21 0.02 
Cholesterol mmol/l 3.96 ±1.25 3.56 ±0.96 0.22 
LDL cholesterol mmol/l 2.06 ±0.93 1.60 ±0.79 0.06 
CRP mg/l 6.5 (2-13) 4 (1.3-8.3) 0.17 
Β2 microglobumin mg/l 28.2 (22.5-34.5) 25.1 (17.1-32.3) 0.09 
Urea reduction ratio 73.3 ±7.4 73.8 ±7.8 0.81 
Sessional Kt/Vurea 1.55 ±0.32 1.58 ±0.35 0.74 
Session time h 3.64 ±0.53 3.59 ±0.52 0.73 
Convection volume L 15.2 ±2.3 16.5±3.7 0.13 
G N/kg/day 1.62 ±0.49 1.25 ±0.28 <0.01 
 539 
 540 
21 
 
 541 
Conflicts of interest  Neither author has any conflict of interest 542 
Funding   Royal Free Hospital 543 
the results presented in this paper have not been published previously in whole 544 
or part form 545 
 546 
